Numerous treatments have been proposed for Peyronie's disease (PD). As the evidence
base has expanded, the field of operative and non-operative options for patients has …

Penile plication has become the preferred surgical technique for Peyronie's disease (PD) as
it can be performed efficiently, safely, with a high success rate, low morbidity and a low …

Xiaflex®(collagenase clostridium histolyticum) is a Food and Drug Administration-approved
treatment for patients with Peyronie's disease. Despite its approval and implementation …

Objective To understand patient and practice-level factors impacting postoperative imaging
use after ureteroscopy (URS) for urinary stone disease. Methods The Michigan Urological …

Introduction: In 2013 injection of collagenase clostridium histolyticum became the first
nonsurgical FDA (Food and Drug Administration) approved treatment for Peyronie's disease …

Background Despite many available treatments for Peyronie's disease (PD), practice
patterns of available therapeutics are not well characterized. Objective We conducted a …

Introduction Peyronie's disease (PD) is a progressive and devastating penile disorder that
often results in severe penile curvature with penile shrinking, making vaginal insertion …

Abstract Background Collagenase Clostridium histolyticum (CCH), which was approved by
the FDA for the treatment of Peyronie's disease (PD) in 2013, may obviate the need for …

The pathophysiology of penile defects requiring surgical reconstruction may be classified
into injuries of the soft tissue and skin, tunica albuginea (TA), and corpora cavernosa …

Introduction: Peyronie's disease is a potentially debilitating connective tissue disorder of the
penis that at times requires surgical intervention. There is a dearth of multi-center or …